
AI Robotics in Medicine
PublicTracking updates in AI Robotics in the healthcare industry
Canada funds AI hub to speed licensing for foreign-trained OTs
Thursday, Jun 25, 2026
Healthcare automation is moving from innovation to deployment: Microbot’s FDA-cleared, single-use LIBERTY endovascular robot earned an innovation award as utilization rises post–April market release across leading U.S. academic centers, while Canada is funding a bilingual AI hub to streamline licensing for internationally educated occupational therapists by late 2026.
Both aim to relieve system bottlenecks—enhancing procedural efficiency and safety, and simplifying a fragmented credentialing path amid an OT workforce shortfall—so watch LIBERTY’s adoption trajectory and whether the Canadian hub measurably eases IEOT pathways and boosts throughput.
Tracking: Medicine Robotics · AI Medicine · AI Healthcare
Geography: United States, European Union, United Kingdom, Israel, China, Japan, South Korea, India, Canada, Singapore
1. Microbot Medical wins SRT Innovative Start-Up Award for LIBERTY robot
Microbot Medical announced it won the Innovative Start-Up Award from Surgical Robotics Technology, together with QNX, on June 25, 2026. The award recognizes highly innovative technologies with potential for broad healthcare impact.
The company’s LIBERTY Endovascular Robotic System is described as the only FDA-cleared, single-use, remotely operated robotic system for peripheral endovascular procedures, designed for precise vascular navigation and to enhance efficiency while aiming to reduce radiation exposure and physical strain.
Microbot reports continued adoption and increased utilization since LIBERTY’s Full Market Release in early April. The system is now in use at leading academic centers across NY, PA, FL, GA, MA, MI, and NC.
The company framed the recognition as validation of LIBERTY’s growing role in advancing robotic-assisted endovascular care and expanding access to innovative procedural technologies.
Key facts:
- Announcement date: June 25, 2026.
- Award: Surgical Robotics Technology Innovative Start-Up Award, in partnership with QNX.
- LIBERTY is FDA-cleared, single-use, and remotely operated for peripheral endovascular procedures.
- Full Market Release occurred in early April.
- Now used at academic centers across NY, PA, FL, GA, MA, MI, and NC.
Why it matters: Third-party recognition plus early multi-state uptake can strengthen credibility in hospital procurement cycles.
LIBERTY’s single-use, remotely operated design—aimed at efficiency and lowering radiation exposure and physical strain—aligns with safety and staffing pressures in endovascular suites.
Watch for the pace of site expansion, evidence of sustained utilization, and data showing efficiency or radiation-safety gains, which would further support broader adoption of endovascular robotics.
2. Canada backs AI hub to speed licensing of foreign-trained occupational therapists
Canada's occupational therapy association (CAOT) announced the upcoming launch of the Canadian Hub for Internationally Educated Occupational Therapists, funded by the Government of Canada and slated for late 2026.
The bilingual, interactive platform uses AI and personalized guidance to simplify licensing for internationally educated occupational therapists.
Features include an AI-powered chatbot for real-time answers, step-by-step guidance aligned with national regulatory requirements, and interactive self-assessments, decision trees, and checklists.
The move targets a persistent workforce gap: one forecast estimates 11,800 OT job openings from 2019-2028 against 9,600 job seekers.
While licensed OTs surpassed 21,000 in 2023, demand still outpaces supply, and IEOT applications to Canada's SEAS process rose from 110 in 2020 to 177 in 2022.
The hub aims to replace a fragmented, high-anxiety journey with a centralized roadmap and builds on programs like UBC's PIE-OT.
Key facts:
- CAOT announced the hub on June 25, 2026.
- Platform slated for a late 2026 release.
- The hub is funded by the Government of Canada.
- An AI-powered chatbot will provide real-time answers and support.
- Guidance aligns with national regulatory requirements and includes interactive tools.
Why it matters: If executed as planned, the hub could shorten onboarding for internationally educated therapists, reduce administrative friction and exam-related anxiety, and partially relieve staffing pressures in hospitals and community care.
By centralizing fragmented requirements into a guided pathway, it lowers barriers that have kept qualified clinicians from practicing. This also pilots AI chatbots in a regulated, high-stakes licensing workflow.
Outcomes from this implementation could shape how other Canadian health professions use AI-driven guidance to accelerate credential recognition and workforce integration.